MyMSMentor: an AI coach to help people manage lifelong chronic conditions
Building and Validating Lifelong Self-Management Capacity with Advanced AI: MyMSMentor
An AI-based coach that learns your daily needs to give personalized, just-in-time support for people with multiple sclerosis and other long-term conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11194277 on NIH RePORTER |
What this research studies
If I use MyMSMentor, an AI agent will learn about my habits, resources, and changing needs to give timely guidance for self-care. The system combines behavior-change science (HAPA) with AI algorithms to model my state and offer personalized prompts and recommendations. It is being built to support lifelong, adaptive self-management and to be useful for people with MS as well as other chronic illnesses. The team plans to test that the system personalizes advice over time and can work across different conditions.
Who could benefit from this research
Good fit: Adults living with multiple sclerosis or other chronic conditions who are interested in smartphone- or app-based self-management support and want personalized coaching.
Not a fit: People without a chronic condition, those who cannot or do not want to use digital tools, or individuals with severe cognitive impairment that prevents interacting with an app may not benefit.
Why it matters
Potential benefit: If successful, this could help people better stick to daily care, reduce symptom flares, and make living with chronic conditions easier and less costly.
How similar studies have performed: Some digital health coaching programs have produced modest improvements in self-management, but lifelong, AI-driven personalization tied to HAPA theory is a relatively new and less-tested approach.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Chiu, Chung-Yi — University of Illinois at Urbana-Champaign
- Study coordinator: Chiu, Chung-Yi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.